Pamisell has ranked among the top searched stocks for 12 days in the past month.
As of 12:30 PM on the 25th, Pamisell is trading at 18,000 KRW, up 5.26% from the previous day. This is a 19.64% decrease compared to August 31. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners have a tentative net purchase of 177,244 shares. Over the past five days, individual investors have net sold 73,059 shares, while foreigners and institutions have net bought 37,261 shares and 34,929 shares respectively.
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
